Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
JCSE01 - Perspectives for Lung Cancer Early Detection
- 07:30 - 11:15
- 9/23/2018
- Location: Room 202 BD
- Type: Joint IASLC/CSCO/CAALC Session
- Track: Screening and Early Detection
-
+
JCSE01.19 - ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line
11:15 - 11:15 | Presenter: Baohui Han | Author(s): Jun Lu, Wei Zhang, Bo Yan, Lele Zhang, Jie Qian, Bo Zhang, Shuyuan Wang
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-29 - Crizotinib in Advanced Lung Adenocarcinoma Patients with ALK or ROS-1 Rearrangement: Is it the Same?
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Bo Zhang, Jianlin Xu, Yanwei Zhang, Xueyan Zhang, Tianqing Chu, Shuyuan Wang, Rong Qiao, Jie Qian, Jun Lu, Lele Zhang
- Abstract
Loading... -
+
P1.01-30 - Crizotinib in Advanced Non-Adenocarcinoma, NSCLC (NA-NSCLC) Patients with ALK Rearrangement: A Retrospective Study and Literature Review
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Bo Zhang, Yanwei Zhang, Jianlin Xu, Xueyan Zhang, Tianqing Chu, Shuyuan Wang, Jie Qian, Rong Qiao, Jun Lu, Lele Zhang
- Abstract
Loading...
-
+
P1.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.03-05 - Transcriptome Landscape of Lung Adenocarcinoma Patients Revealed Distinct Trajectory Patterns
16:45 - 18:00 | Presenter: Yuqing Lou | Author(s): Yanwei Zhang, Jianlin Xu, Wei Zhang, Xueyan Zhang, Rong Li, Baohui Han
- Abstract
Loading... -
+
P1.03-16 - Anlotinib Inhibits Angiogenesis of Refractory Advanced Non-Small Cell Lung Cancer via Blocking CCL2 Expression
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Jun Lu, Hua Zhong, Tianqing Chu, Xueyan Zhang, Rong Li, Jiayuan Sun, Runbo Zhong, Yuqing Yang, Mohammad Shah Alam, Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Wu, Xiaowei Li, Xiaodong Zhao, Kai Li, Liming Lu
- Abstract
Loading... -
+
P1.03-22 - MiR-125b Plays a Tumor Suppressor Role in Inflammation-Related Non-Small Cell Lung Cancer via Repressing IGF-1 Signal Pathway
16:45 - 18:00 | Presenter: Yanwei Zhang | Author(s): Yuqing Lou, Beibei Sun, Xueyan Zhang, Baohui Han
- Abstract
Loading... -
+
P1.03-30 - The Number of Mutated Repair Genes as Predictor for Tumor Mutation Burden of Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Yuqing Lou | Author(s): Yanwei Zhang, Jianlin Xu, Xueyan Zhang, Wei Zhang, Rong Li, Baohui Han
- Abstract
Loading...
-
+
P1.05 - Interventional Diagnostics/Pulmonology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.05-24 - Clinical Characteristics and Prognostic Analysis of Multiple Primary Malignant
Neoplasms in Patients with Lung Cancer16:45 - 18:00 | Presenter: Huijuan Wang | Author(s): Jingjing Hou, Guowei Zhang, Mina Zhang, Xiaojuan Zhang, Zhiyong Ma
- Abstract
Loading...
-
+
P1.11 - Screening and Early Detection (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.11-19 - Expression of TNFRII in Serum is Correlated with the Significant Risk of Subcentimeter Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Yanwei Zhang | Author(s): Xueyan Zhang, Yuqing Lou, Tianqing Chu, Baohui Han
- Abstract
Loading...
-
+
P2.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.03-22 - OCT4&SOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice
16:45 - 18:00 | Presenter: Fang Hu | Author(s): Xueyan Zhang, Xiaoxuan Zheng, Bo Zhang, Huimin Wang, Guangyu Tao, Jianlin Xu, Yanwei Zhang, Baohui Han
- Abstract
Loading... -
+
P2.03-37 - The Efficiency of Octamer-4 Specific Cytotoxic T Cells Induce By CD40-B Cells in Killing Lung Cancer Stem-Like Cells
16:45 - 18:00 | Presenter: Fang Hu | Author(s): Xueyan Zhang, Jianlin Xu, Huimin Wang, Xiaoxuan Zheng, Yanwei Zhang, Yuqing Lou, Baohui Han
- Abstract
Loading...
-
+
P2.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.12-17 - Prophylactic Cranial Irradiation Can Not Provide Survival Benefits for Resected Small Cell Lung Cancer Without Lymph Node Involvement
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Jianlin Xu, Rong Qiao, Jiajun Teng, Bo Zhang, Shuyuan Wang, Jie Qian, Yuqing Lou, Yanwei Zhang, Xueyan Zhang, Xiaolong Fu, Tianqing Chu, Hua Zhong
- Abstract
Loading...
-
+
P2.15 - Treatment in the Real World - Support, Survivorship, Systems Research (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.15-22 - Optimal Glycemic Control Improves Prognosis for Lung Cancer Patients with Diabetes Mellitus
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Jie Qian, Wei Zhang, Xueyan Zhang, Lin Wang, Hua Zhong
- Abstract
Loading...
-
+
P3.13 - Targeted Therapy (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.13-09 - ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line
12:00 - 13:30 | Presenter: Baohui Han | Author(s): Jun Lu, Wei Zhang, Bo Yan, Lele Zhang, Jie Qian, Bo Zhang, Shuyuan Wang
- Abstract
Loading... -
+
P3.13-24 - Efficacy of EGFR-TKIs Compared with Chemotherapy as First-Line Therapy in Patients with EGFR Rare Mutation Advanced Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Huijuan Wang | Author(s): Haixia Li, Mina Zhang, Guowei Zhang, Xiaojuan Zhang, Zhiyong Ma
- Abstract
Loading...